Week Ahead: ISTH Abstracts (COAG & Star); HNSA Capital Markets Day

Research evidence excerpt

Week Ahead: ISTH Abstracts (COAG & Star); HNSA Capital Markets Day

USA | Biotechnology EquityJuneResearch21, 2026

Week Ahead: ISTH Abstracts (COAG & Star);

HNSA Capital Markets Day

ISTH (7/11-7/15) bleeding/thrombotic disorder abstracts post 6/26 for COAG &

Star Therapeutics (acquired by INCY here) updates 7/13. HNSA will host Capital

Markets Day 6/25, featuring ConfIdeS ph.III & EU PAES data review and U.S.

pre-launch/commercial plans for imlifidase ahead of pot'l approval. EAN (June

27-30) abstracts post 6/26. ESMO GI (July 1-July 4) reg abstracts post 6/24.

ASCO Breakthrough (June 25–27) abstracts post 6/22.

Upcoming medical confs

ASCO Breakthrough (June 25–27): Abstracts post June 22 @5PM ET•

European Association of Neurology (June 27-30): abstracts post June 26 @12:30PM ET•

International Rett Syndrome Foundation (June 29–July 1): program here•

ESMO World Congress on GI Cancer (July 1-July 4): Reg abstracts post June 24 @6:05PM•

ET, LBA abstracts post June 29 @6:05 PM ET

Intl Society on Thrombosis & Haemostasis (July 11-July 15): Reg abstracts post June 26•

@9 AM ET

Alzheimer's Assoc. Intl Conference (July 12-July 15): abstracts will be available online to•

registered AAIC attendees only ~two weeks prior to the conf

Clinicaltrials.gov updates

ARWR started recruiting at 8 sites (recruiting at 9 in total) for ARO-DIMERPA (PCSK9 and•

APOC3 RNAi) in mixed hyperlipidemia ph.I/II (n=78; NCT07223658) as of 6/15

CRSP started recruiting for ph.I/II (n=60; NCT07549698) in relapsed/refractory hematologic•

autoimmune disease (ITP & wAIHA) with 3 initial sites as of 6/15

DNTH gMG ph.III (n~95; NCT07647510) posted as of 6/15•

IDYA started recruting at 10 sites (recruting at 14 in total) for IDE034 (PTK7xB7H3 TOP1 ADC)•

ph.I (n~150; NCT07503808) as of 6/18

Regulatory tracker